Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07560631 · ClinicalTrials.gov registry record · NA
SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury
A NA study, sponsored by Stony Brook University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07560631 is a NA study that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 80 participants.
The verdict
NCT07560631, a NA study, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Objective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments, such as the Glasgow Coma Scale (GCS) and Coma Recovery Scale-Revised (CRS-R), rely on subjective human observation and often fail to detect low-amplitude motor responses, potentially misclassifying up to 25% of patients as unresponsive. Methodology: SeeMe utilizes vector analysis, cross-correlation, and deep neural networks (DNNs) to track individual facial pores and hand movements with sub-millimeter precision (0.5 mm) and high temporal resolution (0.03s). The study will enroll a cohort of 60-80 TBI patients, alongside healthy controls and pharmacologically paralyzed subjects, to validate SeeMe's sensitivity and specificity. Primary Goals: 1. Validation: Compare SeeMe's detection of voluntary motor recovery against gold-standard clinical examinations (CRS-R). 2. Synchronization: Simultaneously record and time-lock electroencephalography (EEG) and electrocorticography (ECoG) with SeeMe-detected movements. 3. Biomarker Identification: Characterize neural signatures (specifically Beta-band oscillations) associated with the return of voluntary behavior. Impact: By providing a real-time, objective measure of motor intention and execution, SeeMe aims to identify "Cognitive-Motor Dissociation" (CMD) earlier than current methods, facilitating more accurate prognostications and laying the framework for future closed-loop neuromodulation (e.g., Vagus Nerve Stimulation) to accelerate TBI recovery.
Interventions
- DIAGNOSTIC_TEST SeeMe Multimodal Auditory Command Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2029-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07560631
The ClinicalTrials.gov registry entry for NCT07560631 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SeeMe Multimodal Auditory Command Protocol is the first listed.
NCT07560631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07560631 about?
NCT07560631 is a clinical study titled "SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury". Objective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments, such as the Glasgow...
What is the current status of trial NCT07560631?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-03-30. Estimated completion is 2029-12.
What interventions are being tested in trial NCT07560631?
The interventions under investigation include: SeeMe Multimodal Auditory Command Protocol (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07560631?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.